Concepedia

Xia Bu

XB

Statistics

Publications

28

Citations

9.7K

H-Index

22

Active since

2002

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

Boston Children's Hospital

Xia Bu is an author at Harvard University specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2002–2023

28

Publications

28

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang, Shengqing Gu, Deng Pan et al. · Nature Medicine · 2018 · 5.6K citations · Full text

, , +14

Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance

Jinfang Zhang, Xia Bu, Haizhen Wang et al. · Nature · 2017 · 1K citations · Full text

, , +17

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy

Yang Gao, Naoe Taira Nihira, Xia Bu et al. · Nature Cell Biology · 2020 · 393 citations · Full text

, , +16

TIM-family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-associated Phosphatidylserine

Stephanie Jemielity, Jinyize J. Wang, Ying Chan et al. · PLoS Pathogens · 2013 · 352 citations · Full text

, , +17

T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells

Rosemarie H. DeKruyff, Xia Bu, Ángela Ballesteros et al. · The Journal of Immunology · 2010 · 331 citations · Full text

, , +13

1–5 of 28